Development and function of the splenic marginal zone

Critical Reviews in Immunology

Volumn 24, Issue 6, 2004, Pages 449-464

  Mebius, Reina E ^a   Nolte, Martijn A ^b   Kraal, Georg ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

Marginal metallophilic macrophages; Marginal zone B cells; Marginal zone macrophages; Pathogen defense

Indexed keywords

SCAVENGER;

ANIMAL CELL; B LYMPHOCYTE; BLOOD FILTER; CELL POPULATION; IMMUNITY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN FUNCTION;

ANIMALS; B-LYMPHOCYTES; HUMANS; SPLEEN;

EID: 15444368037     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v24.i6.40     Document Type: Review

References (133)

1. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytology 1992; 132:31-73.
2. Green MC. A defect of the splanchnic mesoderm caused by the mutant gene dominant hemimelia in the mouse. Dev Biol 1967; 15(1):62-89.
3. Roberts CW, Shutter JR, Korsmeyer SJ. Hox11 controls the genesis of the spleen. Nature 1994; 368 (6473):747-749.
4. Godin I, Garcia-Porrero JA, Dieterlen-Lievre F, Cumano A. Stem cell emergence and hemopoietic activity are incompatible in mouse intraembryonic sites. J Exp Med 1999; 190(1):43-52.
5. Delassus S, Cumano A. Circulation of hematopoietic progenitors in the mouse embryo. Immunity 1996; 4(1):97-106.
6. Seifert MF, Marks SCJ. The regulation of hemopoiesis in the spleen. Experientia 1985; 41(2):192-199.
7. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997; 7:493-504.
8. - cells to colonize lymph nodes. Proc Natl Acad Sci U S A 1996; 93:11019-11024.
9. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5(1):64-73.
10. - Cells induce Peyer's patch development: role of α4β1 integrin activation by CXCR5. Immunity 2002; 17(3):363.
11. Fukuyama S, Hiroi T, Yokota Y, Rennert PD, Yanagita M, Kinoshita N, Terawaki S, Shikina T, Yamamoto M, Kurono Y, Kiyono H. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity 2002; 17(1): 31-40.
12. Metcalf D, Moore M. Embryonic aspects of haemopoiesis. In: Neuberger A, Tatum EL, editors. Frontiers of biology. Amsterdam: North-Holland; 1971.
13. Sasaki K, Matsumura G. Spleen lymphocytes and haemopoiesis in the mouse embryo. J Anat 1988; 160:27-37.
14. Morris L, Graham CF, Gordon S. Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80. Development 1991; 112(2):5l7-526.
15. Morris L, Crocker PR, Hill M, Gordon S. Developmental regulation of sialoadhesin (sheep erythrocyte receptor), a macrophage-cell interaction molecule expressed in lymphohemopoietic tissues. Dev Immunol 1992; 2(1):7-17.
16. Velardi A, Cooper MD. An immunofluorescence analysis of the ontogeny of myeloid, T, and B lineage cells in mouse hemopoietic tissues. J Immunol 1984; 133(2):672-677.
17. Rugh R. The mouse: its reproduction and development. Burgess, Minneapolis. 1968.
18. Friedberg SH, Weissman IL. Lymphoid tissue architecture. II. Ontogeny of peripheral T and B cells in mice: evidence against Peyer's patches as the site of generation of B cells. J Immunol 1974; 113(5): 1477-1492.
19. Hecksher-Sorensen J, Watson RP, Lettice LA, Serup P, Eley L, De Angelis C, Ahlgren U, Hill RE. The splanchnic mesodermal plate directs spleen and pancreatic laterality, and is regulated by Bapx1/Nkx3.2. Development 2004; 131(19):4665-4675.
20. Lettice LA, Purdie LA, Carlson GJ, Kilanowski F, Dorin J, Hill RE. The mouse bagpipe gene controls development of axial skeleton, skull, and spleen. Proc Natl Acad Sci U S A 1999; 96(17):9695-9700.
21. Tribioli C, Lufkin T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 1999; 126(24):5699-5711.
22. Dear TN, Colledge WH, Carlton MB, Lavenir I, Larson T, Smith AJ, Warren AJ, Evans MJ, Sofroniew MV, Rabbitts TH. The Hox11 gene is essential for cell survival during spleen development. Development 1995; 121(9):2909-2915.
23. Kanzler B, Dear TN. Hox11 acts cell autonomously in spleen development and its absence results in altered cell fate of mesenchymal spleen precursors. Dev Biol 2001; 234(1):231-243.
24. Lu J, Chang P, Richardson JA, Can L, Weiler H, Olson EN. The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc Natl Acad Sci U S A 2000; 97(17):9525-9530.
25. Herzer U, Crocoll A, Barton D, Howells N, Englert C. The Wilms tumor suppressor gene WT1 is required for development of the spleen. Curr Biol 1999; 9(15):837-840.
26. Koehler K, Franz T, Dear TN. Hox11 is required to maintain normal Wt1 mRNA levels in the developing spleen. Dev Dyn 2000; 218(1):201-206.
27. Takeya M, Takahashi K. Ontogenic development of macrophage subpopulations and ia-positive dendritic cells in fetal and neonatal rat spleen. J Leukoc Biol 1992; 52(5):516-523.
28. Kraal G, Janse M, Claassen E. Marginal metallophilic macrophages in the mouse spleen: effects of neonatal injections of MOMA-1 antibody on the humoral immune response. Immunol Lett 1988; 17:139-144.
29. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54:589-599.
30. Matsuno K, Fujii H, Kotani M. Splenic marginal-zone macrophages and marginal metallophils in rats and mice. Cell Tissue Res 1986; 246(2):263-269.
31. Schmidt EE, MacDonald IC, Groom AC. Microcirculatory pathways in normal human spleen, demonstrated by scanning electron microscopy of corrosion casts. Am J Anat 1988; 181(3):253-266.
32. Kraal G, Schomagel K, Streeter PR, Holzmann B, Butcher EC. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am J Pathol 1995; 147:763-771.
33. Dijkstra CD, Dopp EA. Ontogenetic development of T- and B-lymphocytes and non-lymphoid cells in the white pulp of the rat spleen. Cell Tissue Res 1983; 229(2):351-363.
34. - B lymphocyte subsets. Eur J Immunol 1982; 12:564-569.
35. Kumararatne DS, Bazin H, MacLennan IC. Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol 1981; 11:858-864.
36. Dijkstra CD, Van Vliet E, Dopp EA, Van der Lelij AA, Kraal G. Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities. Immunology 1985; 55(1):23-30.
37. Mitchell J. Lymphocyte circulation in the spleen: marginal zone bridging channels and their possible role in cell traffic. Immunology 1973; 24:93-107.
38. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002; 2(5):323-335.
39. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003; 3(4):292-303.
40. Ruddle NH. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opin Immunol 1992; 4(3):327-332.
41. Ware CF, VanArsdale TL, Crowe PD, Browning JL. The ligands and receptors of the lymphotoxin system, Curr Top Microbiol Immunol 1995; 198:175-218.
42. Fu YX, Chaplin DD. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999; 17:399-433.
43. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994; 264:703-707.
44. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995; 155(4):1685-1693.
45. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, D.D. C. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 1996; 271:1289-1291.
46. Alimzhanov M, Kuprash D, Kosco-Vilbois M, Luz A, Turetskaya R, Tarakhovsky A, Rajewsky K, Nedospasov S, Pfeffer K. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A 1997; 94(17): 9302-9307.
47. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997; 6(4):491-500.
48. Wang J, Foster A, Chin R, Yu P, Sun Y, Wang Y, Pfeffer K, Fu YX. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur J Immunol 2002; 32(7):1969-1979.
49. Ettinger R, Browning JL, Michie SA, van Ewijk W, McDevitt HO. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. Proc Natl Acad Sci U S A 1996; 93(23):13102-13107.
50. Rennert PD, Browning JL, Mebius RE, Mackay F, Hochman PS. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J Exp Med 1996; 184:1999-2006.
51. Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol 1997; 27(8):2033-2042.
52. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998; 9(1):59-70.
53. Pasparakis M, Kousteni S, Peschon J, Kollias G. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell Immunol 2000; 201(1):33-41.
54. Neumann B, Machleidt T, Lifka A, Pfeffer K, Vestweber D, Mak TW, Holzmann B, Kronke M. Crucial role of 55-kilodalton tnf receptor in tnf-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 1996; 156(4):1587-1593.
55. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF-α-deficient mice: A critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996; 184:1397-1411.
56. Körner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, Köntgen F, Fazekas de St Groth B, Sedgwick JD. Distinct role for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 1997; 27:2600-2609.
57. Le Hir M, Bluethmann H, Kosco-Vilbois MH, Muller M, di Padova F, Moore M, Ryffel B, Eugster HP. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med 1996; 183(5):2367-2372.
58. Neumann B, Luz A, Pfeffer K, Holzmann B. Defective peyer's patch organogenesis in mice lacking the 55-kd receptor for tumor necrosis factor. J Exp Med 1996; 184(1):259-264.
59. Rennert PD, Browning JL, Hochman PS. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol 1997; 9(11):1627-1639.
60. Matsumoto M, Fu Y-X, Molina H, Huang G, Kim J, Thomas DA, Nahm MH, Chaplin DD. Distinct roles of lymphotoxin α and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J Exp Med 1997; 186(12):1997-2004.
61. Tkachuk M, Bolliger S, Ryffel B, Pluschke G, Banks TA, Herren S, Gisler RH, Kosco-Vilbois MH. Crucial role of tumor necrosis factor receptor I expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J Exp Med 1998; 187(4):469-477.
62. -/-) donors to wild-type hosts: implications for the generation of architectural events in lymphoid B cell domains. J Immunol 1998; 161:3836-3843.
63. Endres R, Alimzhanov M, Plitz T, Futterer A, Kosco-Vilbois M, Nedospasov S, Rajewsky K, Pfeffer K. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 1999; 189(1): 159-168.
64. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12(1):141-179.
65. Ghosh S, May MJ, Kopp EB. NF-κB and REL proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16(1): 225-260.
66. Mercurio F, Manning AM. Multiple signals converging on NF-κB. Curr Opin Cell Biol 1999; 11(2): 226-332.
67. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18(18):2195-224.
68. Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, Suzuki M, Kogishi K, Serikawa T, Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-kappa b-inducing kinase. Nat Genet 1999; 22(1):74-77.
69. Koike R, Nishimura T, Yasumizu R, Tanaka H, Hataba Y, Hataba Y, Watanabe T, Miyawaki S, Miyasaka M. The splenic marginal zone is absent in alymphoplastic aly mutant mice. Eur J Immunol 1996; 26(3):669-775.
70. Yamada T, Mitani T, Yorita K, Uchida D, Matsushima A, Iwamasa K, Fujita S, Matsumoto M. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-{kappa}B-inducing kinase. J Immunol 2000; 165(2):804-812.
71. -/-) mutant mice. J Exp Med 1997; 185(12):2157-2170.
72. Miyawaki S, Nakamura Y, Suzuka H, Koba M, Yasumizu R, Ikehara S, Shibata Y. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 1994; 24(2):429-434.
73. Matsumoto M, Iwamasa K, Rennert PD, Yamada T, Suzuki R, Matsushima A, Okabe M, Fujita S, Yokoyama M. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. J Immunol 1999; 163(3):1584-1591.
74. VanArsdale TL, VanArsdale SL, Force WR, Walter BN, Mosialos G, Kieff E, Reed JC, Ware CF. Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappa B. Proc Natl Acad Sci U S A 1997; 94(6):2460-2465.
75. Weih D, Yilmaz Z, Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 2001; 167(4):1909-1919.
76. Weih F, Caamano J. Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway. Immunol Rev 2003; 195:91-105.
77. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189(2):403-412.
78. Nolte MA, Hoen EN, van Stijn A, Kraal G, Mebius RE. Isolation of the intact white pulp. Quantitative and qualitative analysis of the cellular composition of the splenic compartments. Eur J Immunol 2000; 30(2):626-634.
79. van den Berg TK, Breve JJ, Damoiseaux JG, Dopp EA, Keim S, Crocker PR, Dijkstra CD, Kraal G. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J Exp Med 1992; 176(3):647-655.
80. Munday J, Floyd H, Crocker PR. Sialic acid binding receptors (siglecs) expressed by macrophages. J Leukoc Biol 1999; 66(5):705-711.
81. Crocker PR, Kelm S, Dubois C, Martin B, McWilliam AS, Shotton DM, Paulson JC, Gordon S. Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. Embo J 1991; 10(7):1661-1669.
82. Keim S, Schauer R, Manuguerra JC, Gross HJ, Crocker PR. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj J 1994; 11(6):576-585.
83. Crocker PR, Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol 2001; 22(6):337-342.
84. Crocker PR, Freeman S, Gordon S, Kelm S. Sialoadhesin binds preferentially to cells of the granulocytic lineage. J Clin Invest 1995; 95(2):635-643.
85. Crocker PR, Hartnell A, Munday J, Nath D. The potential role of sialoadhesin as a macrophage recognition molecule in health and disease. Glycoconj J 1997; 14(5):601-609.
86. Kraal G, Rodrigues H, Hoeben K, Van Rooijen N. Lymphocyte migration in the spleen: the effect of macrophage elimination. Immunology 1989; 68:227-232.
87. Nath D, Hartnell A, Happerfield L, Miles DW, Burchell J, Taylor-Papadimitriou J, Crocker PR. Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin. Immunology 1999; 98(2):213-219.
88. Jones C, Virji M, Crocker PR. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol 2003; 49(5):1213-1225.
89. Eloranta ML, Alm GV. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand J Immunol 1999; 49(4):391-394.
90. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002; 111(7): 927-930.
91. Kang YS, Yamazaki S, Iyoda T, Pack M, Bruening SA, Kim JY, Takahara K, Inaba K, Steinman RM, Park CG. SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. Int Immunol 2003; 15(2):177-186.
92. Kang YS, Kim JY, Bruening SA, Pack M, Charalambous A, Pritsker A, Moran TM, Loeffler JM, Steinman RM, Park CG. The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci U S A 2004; 101 (1):215-220.
93. Geijtenbeek TB, Groot PC, Nolte MA, van Vliet SJ, Gangaram-Panday ST, van Duijnhoven GC, Kraal G, van Oosterhout AJ, van Kooyk Y. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 2002; 100(8):2908-2916.
94. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995; 80(4):603-609.
95. van der Laan LJ, Dopp EA, Haworth R, Pikkarainen T, Kangas M, Elomaa O, Dijkstra CD, Gordon S, Tryggvason K, Kraal G. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999; 162(2):939-947.
96. Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Krieger E, Vriend G, Figdor CG, van Kooyk Y. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J Biol Chem 2002; 277(13):11314-11320.
97. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000; 151(3):673-684.
98. Van Rooijen N. Antigen processing and presentation in vivo: the microenvironment as a crucial factor. Immunol Today 1990; 11:436-439.
99. Peng KW, Frenzke M, Myers R, Soeffker D, Harvey M, Greiner S, Galanis E, Cattaneo R, Federspiel MJ, Russell SJ. Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic mice. Hum Gene Ther 2003; 14(16):1565-1577.
100. Oehen S, Odermatt B, Karrer U, Hengartner H, Zinkernagel R, Lopez-Macias C. Marginal zone macrophages and immune responses against viruses. J Immunol 2002; 169(3):1453-1458.
101. Karlsson MC, Guinamard R, Holland S, Sankala M, Steinman RM, Ravetch JV. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 2003; 198(2):333-340.
102. Nolte MA, Arens R, Kraus M, van Oers MH, Kraal G, van Lier RA, Mebius RE. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol 2004; 172(6):3620-3627.
103. Crowley MT, Relly CR, Lo D. Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. J Immunol 1999; 163(9):4894-4900.
104. Kraal G, van der Laan LJ, Elomaa O, Tryggvason K. The macrophage receptor MARCO. Microbes Infect 2000; 2(3):313-316.
105. Pikkarainen T, Brannstrom A, Tryggvason K. Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes. J Biol Chem 1999; 274(16):10975-10982.
106. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997; 27:2366-2374.
107. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14(5):617-629.
108. Oliver AM, Martin F, Kearney JF. IgM high CD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999; 162(12):7198-7207.
109. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev 2004; 197:192-205.
110. Gray D, Kumararatne DS, Lortan J, Khan M, MacLennan IC. Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology 1984; 52(4):659-669.
111. Heinen E, Braun M, Coulie PG, Van Snick J, Moeremans M, Cormann N, Kinet-Denoel C, Simar LJ. Transfer of immune complexes from lymphocytes to follicular dendritic cells. Eur J Immunol 1986; 16(2):167-172.
112. Witt CM, Won WJ, Hurez V, Klug CA. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol 2003; 171(6):2783-2788.
113. Saito T, Chiba S, Ichikawa M, Kunisato A, Asai T, Shimizu K, Yamaguchi T, Yamamoto G, Seo S, Kumano K, Nakagami-Yamaguchi E, Hamada Y, Aizawa S, Hirai H. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 2003; 18(5):675-685.
114. Tanigaki K, Han H, Yamamoto N, Tashiro K, Ikegawa M, Kuroda K, Suzuki A, Nakano T, Honjo T. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol 2002; 3(5):443-450.
115. Kuroda K, Han H, Tani S, Tanigaki K, Tun T, Furukawa T, Taniguchi Y, Kurooka H, Hamada Y, Toyokuni S, Honjo T. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/ RBP-J signaling pathway. Immunity 2003; 18(2): 301-312.
116. Quong MW, Martensson A, Langerak AW, Rivera RR, Nemazee D, Murre C. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J Exp Med 2004; 199(8):1101-1112.
117. Cinamon G, Matloubian M, Lesneski MJ, Xu Y, Low C, Lu T, Proia RL, Cyster JG. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 2004; 5(7):713-720.
118. Groeneveld PH, van Rooijen N, Eikelenboom P. In-vivo effects of lipopolysaccharide on lymphoid and non-lymphoid cells in the mouse spleen. Migration of marginal metallophils towards the follicle centres. Cell Tissue Res 1983; 234:201-208.
119. Lu IT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002; 297(5580):409-412.
120. Nombela-Arrieta C, Lacalle RA, Montoya MC, Kunisaki Y, Megias D, Marques M, Carrera AC, Manes S, Fukui Y, Martinez AC, Stein JV. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 2004; 21(3):429-441.
121. Fukui Y, Hashimoto O, Sanui T, Oono T, Koga H, Abe M, Inayoshi A, Noda M, Oike M, Shirai T, Sasazuki T. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001; 412(6849):826-831.
122. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV. Absence of marginal zone B cells in Pyk-2 deficient mice defines their role in the humoral response. Nat Immunol 2000; 1(1):31-36.
123. Girkontaite I, Missy K, Sakk V, Harenberg A, Tedford K, Potzel T, Pfeffer K, Fischer KD. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001; 2(9):855-862.
124. Ato M, Nakano H, Kakiuchi T, Kaye PM. Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21/19. J Immunol 2004; 173(8):4815-4820.
125. Kraal G, Mebius RE. High endothelial venules: Lymphocyte traffic control and controlled traffic. Adv Immunol 1997; 65:347-395.
126. Lyons AB, Parish CR. Are murine marginal-zone macrophages the splenic white pulp analog of high endothelial venules? Eur J Immunol 1995; 25: 3165-3172.
127. Cyster JG, Goodnow CC. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 1995; 182:581-586.
128. Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003; 195: 117-135.
129. Lo CG, Lu TT, Cyster JG. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 2003; 197(3):353-361.
130. Nolte MA, Hamann A, Kraal G, Mebius RE. The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 2002; 106(3):299-307.
131. Leisewitz AL, Rockett KA, Gumede B, Jones M, Urban B, Kwiatkowski DP. Response of the splenic dendritic cell population to malaria infection. Infect Immun 2004; 72(7):4233-4239.
132. Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Papworth GD, Wang Z, Watkins SC, Falo LD, Jr., Thomson AW. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101(2):611-620.
133. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999; 189:451-460.